SAVE THE DATE: WADA to hold Therapeutic Use Exemption Symposium in 2023

The World Anti-Doping Agency (WADA) kindly asks its stakeholders to ‘save the date’ for its Therapeutic Use Exemption (TUE) Symposium, which was postponed in 2021 and 2022 due to the COVID-19 pandemic and is now scheduled to be held from 31 May to 2 June 2023 in Incheon, South Korea.

This is WADA’s fifth TUE Symposium, which will graciously be co-hosted by the Korea Anti-Doping Agency (KADA). The Symposium will convene TUE Expert Advisory Group members (physicians) and those that manage TUEs from National Anti-Doping Organizations, International Federations, Major Event Organizations and other international sports organizations from around the globe to discuss medical conditions and the TUE process.

The primary objective of the TUE Symposium is to harmonize the approach to TUEs, which ensures that athletes with legitimate medical conditions may participate in sport despite their need for a medication or treatment that may otherwise be prohibited. The Symposium will include interactive discussions on medical cases, medico-legal issues, and retroactive TUEs. Participants will also discuss challenges regarding global harmonization of practices, with the goal of ensuring that fairness is maintained; and, that athletes are afforded similar opportunities regardless of their sport, geographical location or specific medical issues. To maximize stakeholder interaction, booths will be set up so that participants can chat with WADA Medical staff and other experts about specific medical conditions and the TUE process.

We invite stakeholders to contact WADA’s Medical Department at This email address is being protected from spambots. You need JavaScript enabled to view it. to submit any interesting short cases for the session named “Quick Dives: Pearls from around the world.” Those who submit cases may in turn be selected to present their case and convey key takeaways to their fellow attendees.

Please rest assured that WADA is committed to ensuring the health and safety of all in attendance. Accordingly, we will continue to monitor the evolution of the pandemic – along with our Korean hosts – and ensure that any appropriate precautions are taken.

While registration for the Symposium will only open in February 2023, should you have any other questions, please contact Kimberley Chinnarassen, Assistant, Science and Medicine at This email address is being protected from spambots. You need JavaScript enabled to view it. and/or Anaïs Lefevre, WADA’s Events Manager at This email address is being protected from spambots. You need JavaScript enabled to view it..

WADA and KADA look forward to welcoming many of you in Incheon in 2023.

The original press release can be found here : https://www.wada-ama.org/en/news/save-date-wada-hold-therapeutic-use-exemption-symposium-2023

Wednesday, 03 August 2022